News tagged with neurofibromatosis type 2
Anti-angiogenesis treatment improves hearing in some NF2 patients
Jul 08, 2009 |
not rated yet |
0
Treatment with the angiogenesis inhibitor bevacizumab improved hearing and alleviated other symptoms in patients with neurofibromatosis type 2 (NF2). In a paper to appear in the July 23 New England Journal of Medicine, which ...
Search results for neurofibromatosis type 2
Gene's newly explained effect on height may change tumor disorder treatment
Aug 11, 2008 |
5 / 5 (2) |
0
A mutation that causes a childhood tumor syndrome also impairs growth hormone secretion, researchers at Washington University School of Medicine in St. Louis have found.
Research to lead to brain tumor therapies
Mar 24, 2008 |
4.7 / 5 (3) |
1
Unique human in vitro model (cell culture) research currently underway at the Peninsula Medical School in the South West of England is set to identify and develop therapies for the treatment of multiple tumours in the brain.
Study examines challenges of diagnosing neurofibromatosis type 1-like syndrome
Nov 17, 2009 |
not rated yet |
0
An analysis of patients with a syndrome similar to the genetic disorder, neurofibromatosis type 1, indicates that diagnosis may be difficult because of shared clinical findings, such as certain pigmentary characteristics, ...
Cholesterol-lowering drug boosts bone repair
Medicine & Health / Medications
Jul 31, 2008 |
3.6 / 5 (5) |
0
Lovastatin, a drug used to lower cholesterol and help prevent cardiovascular disease, has been shown to improve bone healing in an animal model of neurofibromatosis type 1 (NF1). The research, reported today in the open access ...
Fishing for microdeletions that predispose an embryo to develop cancer syndromes in later life
Mar 10, 2009 |
not rated yet |
0
Researchers have used a common laboratory technique for the first time to detect genetic changes in embryos that could predispose the resulting children to develop certain cancer syndromes. Current preimplantation genetic ...
Researchers identify cells that cause nervous system disease
Feb 04, 2008 |
4.7 / 5 (6) |
0
Two teams of University of Michigan researchers have tracked down the cells responsible for neurofibromatosis type1, a disfiguring, incurable condition and one of the most common hereditary disorders.
Statin does not appear helpful for children with learning disabilities caused by genetic disorder
Jul 15, 2008 |
not rated yet |
0
Use of simvastatin by children with neurofibromatosis type 1 (NF1), a genetic disorder that can cause learning disabilities, did not result in improved cognitive function, according to a study in the July 16 issue of JAMA.
Mouse model for mesothelioma reproduces human disease
Mar 10, 2008 |
not rated yet |
0
Scientists have established a mouse model for human malignant mesothelioma (MM) that will provide valuable insight into cancer development and progression along with new directions for design of therapeutic strategies. The ...
Protein key to neuro-regeneration
Biology /
May 20, 2008 |
4.6 / 5 (10) |
0
Researchers at the Peninsula Medical School in the South West of England, University College London, the San Raffaele Scientific Institute in Milan and Cancer Research UK, have for the first time identified a protein that ...
Loss of tumor supressor gene essential to transforming benign nerve tumors into cancers
Oct 13, 2009 |
4 / 5 (1) |
0
Researchers at UCLA's Jonsson Comprehensive Cancer Center showed for the first time that the loss or decreased expression of the tumor suppressor gene PTEN plays a central role in the malignant transformation of benign nerve ...
List of search results for neurofibromatosis type 2
